Related Experiment Video
Updated: Jul 14, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma
Robert A Smith1, Rod A Lea, Stephen R Weinstein
1Genomics Research Centre and Wesley Research Institute, School of Health Science, Griffith University Gold Coast, QLD, Australia.
Abstract:
Our laboratory has previously found that anti-mitogenic nuclear receptor mRNA is elevated in late stage tumours and this study was performed to scrutinize the possibility of cancer-stroma crosstalk using hormone signaling in these tissues. RNA levels in stromal tissue were examined for the estrogen alpha, estrogen beta, androgen, progesterone and glucocorticoid nuclear receptors by a semi-quantitative PCR. Significant differences in expression between the cancer stroma and control tissue were seen, analyzing for both cancer grade and estrogen receptor status. Stroma and control tissue were significantly different for the progesterone and glucocorticoid nuclear receptors (p=5.908 x 10(-7) and 2.761 x 10(-5), respectively). Glucocorticoid receptor also showed a significant increase to mRNA levels in the stroma of estrogen receptor negative tumours (p=5.85 x 10(-5)). By contrast, the estrogen receptors alpha and beta, those most closely associated with breast tissue growth, showed no significant change in mRNA (p=0.372 and 0.655, respectively). Androgen receptor mRNA also remained unaffected (p=0.174).
Insights
Cancer stroma exhibits altered hormone receptor signaling. Progesterone and glucocorticoid receptor mRNA levels significantly differ in tumor stroma, suggesting potential cancer-stroma crosstalk via hormone signaling pathways.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Previous research indicated elevated anti-mitogenic nuclear receptor mRNA in late-stage tumors.
- Hormone signaling plays a crucial role in various physiological and pathological processes, including cancer development.
Purpose of the Study:
- To investigate the potential for cancer-stroma crosstalk mediated by hormone signaling.
- To examine the expression levels of key nuclear hormone receptors in tumor stromal tissue.
Main Methods:
- Semi-quantitative PCR was employed to analyze RNA levels of estrogen receptors alpha and beta, androgen receptor, progesterone receptor, and glucocorticoid receptor in stromal tissue.
- Expression data was compared between cancer stroma and control tissues, considering cancer grade and estrogen receptor status.
Main Results:
- Significant differences in mRNA expression were observed for progesterone receptor (p=5.908 x 10(-7)) and glucocorticoid receptor (p=2.761 x 10(-5)) between cancer stroma and control tissues.
- Glucocorticoid receptor mRNA levels were significantly increased in the stroma of estrogen receptor-negative tumors (p=5.85 x 10(-5)).
- Estrogen receptors alpha and beta, and androgen receptor mRNA levels showed no significant changes in the stroma.
Conclusions:
- The findings suggest that progesterone and glucocorticoid receptors are involved in cancer-stroma crosstalk.
- Altered expression of these receptors in the tumor microenvironment may contribute to tumor progression.
- Estrogen and androgen signaling pathways appear less involved in this specific crosstalk mechanism in the studied tumor stroma.
Related Concept Videos
The Tumor Microenvironment
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
